keyword
https://read.qxmd.com/read/38596014/computational-approach-for-identifying-immunogenic-epitopes-and-optimizing-peptide-vaccine-through-in-silico-cloning-against-mycoplasma-genitalium
#21
JOURNAL ARTICLE
Asma Akter, Natasha Farhin Ananna, Hedayet Ullah, Sirajul Islam, Md Al Amin, K M Kaderi Kibria, Shahin Mahmud
Mycoplasma genitalium is a pathogenic microorganism linked to a variety of severe health conditions including ovarian cancer, prostate cancer, HIV transmission, and sexually transmitted diseases. A more effective approach to address the challenges posed by this pathogen, given its high antibiotic resistance rates, could be the development of a peptide vaccine. In this study, we used experimentally validated 13 membrane proteins and their immunogenicity to identify suitable vaccine candidates. Thus, based on immunogenic properties and high conservation among other Mycoplasma genitalium sub-strains, the P110 surface protein is considered for further investigation...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38595983/conditionally-replicative-adenovirus-as-a-therapy-for-malignant-peripheral-nerve-sheath-tumors
#22
JOURNAL ARTICLE
Julia A Nikrad, Robert T Galvin, Mackenzie M Sheehy, Ethan L Novacek, Kari L Jacobsen, Stanislas M A S Corbière, Pauline J Beckmann, Tyler A Jubenville, Masato Yamamoto, David A Largaespada
Oncolytic adenoviruses (Ads) stand out as a promising strategy for the targeted infection and lysis of tumor cells, with well-established clinical utility across various malignancies. This study delves into the therapeutic potential of oncolytic Ads in the context of neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors (MPNSTs). Specifically, we evaluate conditionally replicative adenoviruses (CRAds) driven by the cyclooxygenase 2 (COX2) promoter, as selective agents against MPNSTs, demonstrating their preferential targeting of MPNST cells compared with non-malignant Schwann cell control...
June 20, 2024: Mol Ther Oncol
https://read.qxmd.com/read/38593864/trypanosoma-cruzi-killing-and-immune-response-boosting-by-novel-phenoxyhydrazine-thiazole-against-chagas-disease
#23
JOURNAL ARTICLE
Ana Catarina Cristovão-Silva, Maria Carolina Accioly Brelaz-de-Castro, Elis Dionisio da Silva, Ana Cristina Lima Leite, Lizandra Beatriz Amorim Alves Santiago, Juliana Maria da Conceição, Robert da Silva Tiburcio, Davi Pereira de Santana, Danilo Cesar Galindo Bedor, Breno Ítalo Valença de Carvalho, Luiz Felipe Gomes Rebello Ferreira, Rafael de Freitas E Silva, Valéria Rêgo Alves Pereira, Marcelo Zaldini Hernandes
Trypanosoma cruzi (T. cruzi) causes Chagas, which is a neglected tropical disease (NTD). WHO estimates that 6 to 7 million people are infected worldwide. Current treatment is done with benznidazole (BZN), which is very toxic and effective only in the acute phase of the disease. In this work, we designed, synthesized, and characterized thirteen new phenoxyhydrazine-thiazole compounds and applied molecular docking and in vitro methods to investigate cell cytotoxicity, trypanocide activity, nitric oxide (NO) production, cell death, and immunomodulation...
April 7, 2024: Experimental Parasitology
https://read.qxmd.com/read/38593531/design-synthesis-in-silico-and-biological-evaluation-of-new-indole-based-oxadiazole-derivatives-targeting-estrogen-receptor-alpha
#24
JOURNAL ARTICLE
Kamalpreet Kaur, Harkomal Verma, Prabhakar Gangwar, Kailash Jangid, Monisha Dhiman, Vinod Kumar, Vikas Jaitak
A series of new indole-oxadiazole derivatives was designed and synthesized to develop potential anti-breast cancer agents. The compounds exhibited significant inhibitory activity with IC50 values ranging from 1.78 to 19.74 μM against ER-positive human breast cancer (BC) cell lines T-47D and MCF-7. Among them, compounds (5a, 5c, 5e-5h, 5j-5o) displayed superior activity against ER-α dominant (ratio of ER-α/ER-β is 9/1) T-47D cells compared to the standard drug bazedoxifene (IC50  = 12...
April 5, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38592331/unleashing-natural-il18-activity-using-an-anti-il18bp-blocker-induces-potent-immune-stimulation-and-antitumor-effects
#25
JOURNAL ARTICLE
Assaf Menachem, Zoya Alteber, Gady Cojocaru, Tal Fridman Kfir, Dan Blat, Olga Leiderman, Moran Galperin, Lital Sever, Nadav Cohen, Keren Cohen, Roy Z Granit, Sandra Vols, Masha Frenkel, Liron Soffer, Karin Meyer, Keren Menachem, Hadas Galon Tilleman, Dina Morein, Itamar Borukhov, Amir Toporik, Michal Perpinial Shahor, Evgeny Tatirovsky, Aviram Mizrachi, Adva Levy-Barda, Eran Sadot, Yulia Strenov, Ram Eitan, Ariella Jakobson-Setton, Natalia Yanichkin, Pierre Ferre, Eran Ophir
Recombinant cytokines have limited anticancer efficacy mostly due to a narrow therapeutic window and systemic adverse effects. IL18 is an inflammasome-induced proinflammatory cytokine, which enhances T- and NK-cell activity and stimulates IFNγ production. The activity of IL18 is naturally blocked by a high-affinity endogenous binding protein (IL18BP). IL18BP is induced in the tumor microenvironment (TME) in response to IFNγ upregulation in a negative feedback mechanism. In this study, we found that IL18 is upregulated in the TME compared with the periphery across multiple human tumors and most of it is bound to IL18BP...
April 1, 2024: Cancer Immunology Research
https://read.qxmd.com/read/38588339/lack-of-functional-tcr-epitope-interaction-is-associated-with-herpes-zoster-through-reduced-downstream-t%C3%A2-cell-activation
#26
JOURNAL ARTICLE
Marlies Boeren, Nicky de Vrij, My K Ha, Sebastiaan Valkiers, Aisha Souquette, Sofie Gielis, Mariia Kuznetsova, Jolien Schippers, Esther Bartholomeus, Johan Van den Bergh, Nele Michels, Olivier Aerts, Julie Leysen, An Bervoets, Julien Lambert, Elke Leuridan, Johan Wens, Karin Peeters, Marie-Paule Emonds, George Elias, Niels Vandamme, Hilde Jansens, Wim Adriaensen, Arvid Suls, Stijn Vanhee, Niel Hens, Evelien Smits, Pierre Van Damme, Paul G Thomas, Philippe Beutels, Peter Ponsaerts, Viggo Van Tendeloo, Peter Delputte, Kris Laukens, Pieter Meysman, Benson Ogunjimi
The role of T cell receptor (TCR) diversity in infectious disease susceptibility is not well understood. We use a systems immunology approach on three cohorts of herpes zoster (HZ) patients and controls to investigate whether TCR diversity against varicella-zoster virus (VZV) influences the risk of HZ. We show that CD4+ T cell TCR diversity against VZV glycoprotein E (gE) and immediate early 63 protein (IE63) after 1-week culture is more restricted in HZ patients. Single-cell RNA and TCR sequencing of VZV-specific T cells shows that T cell activation pathways are significantly decreased after stimulation with VZV peptides in convalescent HZ patients...
April 7, 2024: Cell Reports
https://read.qxmd.com/read/38587532/quercetin-and-kaempferol-inhibit-hmc-1-activation-via-soce-nfatc2-signaling-and-suppress-hippocampal-mast-cell-activation-in-lipopolysaccharide-induced-depressive-mice
#27
JOURNAL ARTICLE
Pan Su, Zibo Li, Xiangli Yan, Baoying Wang, Ming Bai, Yucheng Li, Erping Xu
OBJECTIVE AND DESIGN: Mast cells (MCs), as the fastest immune responders, play a critical role in the progression of neuroinflammation-related diseases, especially in depression. Quercetin (Que) and kaempferol (Kae), as two major diet-derived flavonoids, inhibit MC activation and exhibit significant antidepressant effect due to their anti-inflammatory capacity. The study aimed to explore the mechanisms of inhibitory effect of Que and Kae on MC activation, and whether Que and Kae suppress hippocampal mast cell activation in LPS-induced depressive mice...
April 8, 2024: Inflammation Research: Official Journal of the European Histamine Research Society ... [et Al.]
https://read.qxmd.com/read/38585731/rag-gtpase-tfeb-tfe3-axis-controls-b-cell-mitochondrial-fitness-and-humoral-immunity-independent-of-mtorc1
#28
Hu Zeng, Xingxing Zhu, Yue Wu, Yanfeng Li, Xian Zhou, Jens Watzlawik, Yin Chen, Ariel Raybuck, Daniel Billadeau, Virginia Shapiro, Wolfdieter Springer, Sun Jie, Mark Boothby
During the humoral immune response, B cells undergo rapid metabolic reprogramming with a high demand for nutrients, which are vital to sustain the formation of the germinal centers (GCs). Rag-GTPases sense amino acid availability to modulate the mechanistic target of rapamycin complex 1 (mTORC1) pathway and suppress transcription factor EB (TFEB) and transcription factor enhancer 3 (TFE3), members of the microphthalmia (MiT/TFE) family of HLH-leucine zipper transcription factors. However, how Rag-GTPases coordinate amino acid sensing, mTORC1 activation, and TFEB/TFE3 activity in humoral immunity remains undefined...
March 29, 2024: Research Square
https://read.qxmd.com/read/38585463/low-affinity-nmda-receptor-antagonist-hemantane-in-a-topical-formulation-attenuates-arthritis-induced-by-freund-s-complete-adjuvant-in-rats
#29
JOURNAL ARTICLE
Elena Ivanova, Alexander Matyushkin, Alexandra Sorokina, Svetlana Alexeeva, Irina Miroshkina, Kirill Kachalov, Tatyana Voronina, Andrey Durnev
PURPOSE: N-methyl-D-aspartate (NMDA) receptors that are expressed by T-cells modulate T-cell proliferation, cytotoxicity and cell migration toward chemokines. Several studies have shown an anti-inflammatory effect of NMDA receptor antagonists. This study compares the effect of the noncompetitive low-affinity NMDA receptor antagonist N-(2-adamantyl)-hexamethyleneimine hydrochloride (hemantane) in a topical formulation (gel) with the cyclooxygenase (COX) inhibitor diclofenac in a topical formulation (gel) in rats with arthritis induced by Freund's Complete Adjuvant (FCA)...
March 2024: Advanced Pharmaceutical Bulletin
https://read.qxmd.com/read/38585266/the-neutralizing-effect-of-heparin-on-blood-derived-antimicrobial-compounds-impact-on-antibacterial-activity-and-inflammatory-response
#30
JOURNAL ARTICLE
Denisa Cont, Stephan Harm, Claudia Schildböck, Claudia Kolm, Alexander K T Kirschner, Andreas H Farnleitner, Matthias Pilecky, Jennifer Zottl, Jens Hartmann, Viktoria Weber
Acting through a combination of direct and indirect pathogen clearance mechanisms, blood-derived antimicrobial compounds (AMCs) play a pivotal role in innate immunity, safeguarding the host against invading microorganisms. Besides their antimicrobial activity, some AMCs can neutralize endotoxins, preventing their interaction with immune cells and avoiding an excessive inflammatory response. In this study, we aimed to investigate the influence of unfractionated heparin, a polyanionic drug clinically used as anticoagulant, on the endotoxin-neutralizing and antibacterial activity of blood-derived AMCs...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38578777/heterozygous-gain-of-function-variant-in-gucy1a2-may-cause-autonomous-ovarian-hyperfunction
#31
JOURNAL ARTICLE
Theresa Wittrien, Alban Ziegler, Anne Rühle, Svenja Stomberg, Ruben Meyer, Dominique Bonneau, Patrice Rodien, Delphine Prunier-Mirebeau, Régis Coutant, Sönke Behrends
PURPOSE: The purpose of this study was to characterize the phenotype associated with a de novo gain-of-function variant in the GUCY1A2 gene. METHODS: An individual carrying the de novo heterozygous variant c.1458G>T p.(E486D) in GUCY1A2 was identified by exome sequencing. The effect of the corresponding enzyme variant α2E486D/β1 was evaluated using concentration-response measurements with wild-type enzyme and the variant in cytosolic fractions of HEK293 cells, UV-vis absorbance spectra of the corresponding purified enzymes, and examination of overexpressed fluorescent protein-tagged constructs by confocal laser scanning microscopy...
March 30, 2024: European Journal of Endocrinology
https://read.qxmd.com/read/38577994/inhibitors-of-the-thioesterase-activity-of-mycobacterium-tuberculosis-pks13-discovered-using-dna-encoded-chemical-library-screening
#32
JOURNAL ARTICLE
Inna V Krieger, Subbarao Yalamanchili, Paige Dickson, Curtis A Engelhart, Matthew D Zimmerman, Jeremy Wood, Ethan Clary, Jasmine Nguyen, Natalie Thornton, Paolo A Centrella, Betty Chan, John W Cuozzo, Martin Gengenbacher, Marie-Aude Guié, John P Guilinger, Corey Bienstock, Hajnalka Hartl, Christopher D Hupp, Rachael Jetson, Takashi Satoh, John T S Yeoman, Ying Zhang, Veronique Dartois, Dirk Schnappinger, Anthony D Keefe, James C Sacchettini
DNA-encoded chemical library (DEL) technology provides a time- and cost-efficient method to simultaneously screen billions of compounds for their affinity to a protein target of interest. Here we report its use to identify a novel chemical series of inhibitors of the thioesterase activity of polyketide synthase 13 (Pks13) from Mycobacterium tuberculosis (Mtb). We present three chemically distinct series of inhibitors along with their enzymatic and Mtb whole cell potency, the measure of on-target activity in cells, and the crystal structures of inhibitor-enzyme complexes illuminating their interactions with the active site of the enzyme...
April 5, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/38577429/computational-studies-and-synthesis-of-131-iodine-labeled-nocardiotide-a-analogs-as-a-peptide-based-theragnostic-radiopharmaceutical-ligand-for-cancer-targeting-sstr2
#33
JOURNAL ARTICLE
Rizky Juwita Sugiharti, Rani Maharani, Fransiska Kurniawan, Rahmana Emran Kartasasmita, Daryono Hadi Tjahjono
Radiolabeled peptides belong to a highly specific group of radiotracers used in oncology, particularly for diagnostics and cancer therapy. With the notable advantages of high binding affinity and selectivity to cancer cells, they have proven to be very useful in nuclear medicine. As a result, efforts have been focused on discovering new peptide sequences for radiopeptide preparation. Nocardiotide A, a cyclic hexapeptide comprising the amino acids cyclo-Trp-Ile-Trp-Leu-Val-Ala (cWIWLVA) isolated from Nocardiopsis sp...
April 3, 2024: RSC Advances
https://read.qxmd.com/read/38577265/transfer-learning-improves-pmhc-kinetic-stability-and-immunogenicity-predictions
#34
JOURNAL ARTICLE
Romanos Fasoulis, Mauricio Menegatti Rigo, Dinler Amaral Antunes, Georgios Paliouras, Lydia E Kavraki
The cellular immune response comprises several processes, with the most notable ones being the binding of the peptide to the Major Histocompability Complex (MHC), the peptide-MHC (pMHC) presentation to the surface of the cell, and the recognition of the pMHC by the T-Cell Receptor. Identifying the most potent peptide targets for MHC binding, presentation and T-cell recognition is vital for developing peptide-based vaccines and T-cell-based immunotherapies. Data-driven tools that predict each of these steps have been developed, and the availability of mass spectrometry (MS) datasets has facilitated the development of accurate Machine Learning (ML) methods for class-I pMHC binding prediction...
March 2024: Immunoinformatics (Amst)
https://read.qxmd.com/read/38575347/inefficient-recruitment-of-ddx39b-impedes-pre-spliceosome-assembly-on-foxp3-introns
#35
JOURNAL ARTICLE
Chloe K Nagasawa, Aaron O Bailey, William Russell, Mariano A Garcia-Blanco
Forkhead box P3 (FOXP3) is the master fate-determining transcription factor in regulatory T (Treg) cells and is essential for their development, function and homeostasis. Mutations in FOXP3 cause immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, and aberrant expression of FOXP3 has been implicated in other diseases such as multiple sclerosis and cancer. We previously demonstrated that pre-mRNA splicing of FOXP3 RNAs is highly sen-sitive to levels of DExD-box polypeptide 39B (DDX39B) and here we investigate the mechanism of this sensitivity...
April 4, 2024: RNA
https://read.qxmd.com/read/38575203/ocimum-kilimandscharicum-4cl11-negatively-regulates-adventitious-root-development-via-accumulation-of-flavonoid-glycosides
#36
JOURNAL ARTICLE
Santosh G Lavhale, Kirtikumar R Kondhare, Veenothini S Sinthadurai, Vitthal T Barvkar, Rutuja S Kale, Rakesh S Joshi, Ashok P Giri
4-Coumarate-CoA Ligase (4CL) is an important enzyme in the phenylpropanoid biosynthesis pathway. Multiple 4CLs are identified in Ocimum species; however, their in planta functions remain enigmatic. In this study, we independently overexpressed three Ok4CL isoforms from Ocimum kilimandscharicum (Ok4CL7, -11, and -15) in Nicotiana benthamiana. Interestingly, Ok4CL11 overexpression (OE) caused a rootless or reduced root growth phenotype, whereas overexpression of Ok4CL15 produced normal adventitious root (AR) growth...
April 4, 2024: Plant Journal
https://read.qxmd.com/read/38574928/in-silico-design-of-high-affinity-antigenic-peptides-for-hla-b44
#37
JOURNAL ARTICLE
Mei Feng, Kevin C Chan, Qinglu Zhong, Ruhong Zhou
Cancer cell-killing by CD8+ T cells demands effective tumor antigen presentation by human leukocyte antigen class I (HLA-I) molecules. Screening and designing highly immunogenic neoantigens require quantitative computations to reliably predict HLA-peptide binding affinities. Here, with all-atom molecular dynamics (MD) simulations and free energy perturbation (FEP) methods, we design a collection of antigenic peptide candidates through in silico mutagenesis studies on immunogenic neoantigens, yielding enhanced binding affinities to HLA-B*44:02...
April 2, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38570883/novel-insights-into-tcr-t-cell-therapy-in-solid-neoplasms-optimizing-adoptive-immunotherapy
#38
REVIEW
Weihuan Shao, Yiran Yao, Ludi Yang, Xiaoran Li, Tongxin Ge, Yue Zheng, Qiuyi Zhu, Shengfang Ge, Xiang Gu, Renbing Jia, Xin Song, Ai Zhuang
Adoptive immunotherapy in the T cell landscape exhibits efficacy in cancer treatment. Over the past few decades, genetically modified T cells, particularly chimeric antigen receptor T cells, have enabled remarkable strides in the treatment of hematological malignancies. Besides, extensive exploration of multiple antigens for the treatment of solid tumors has led to clinical interest in the potential of T cells expressing the engineered T cell receptor (TCR). TCR-T cells possess the capacity to recognize intracellular antigen families and maintain the intrinsic properties of TCRs in terms of affinity to target epitopes and signal transduction...
April 3, 2024: Experimental Hematology & Oncology
https://read.qxmd.com/read/38562878/germinal-center-dark-zone-harbors-atr-dependent-determinants-of-t-cell-exclusion-that-are-also-identified-in-aggressive-lymphoma
#39
Claudio Tripodo, Valeria Cancila, Gaia Morello, Giorgio Bertolazzi, Allison Si-Yu Chan, Giulia Bastianello, Daniel Paysan, Patrick William Jaynes, Giovanna Schiavoni, Fabrizio Mattei, Silvia Piconese, Maria Revuelta, Francesco Noto, Adele De Ninno, Ilenia Cammarata, Fabio Pagni, Saradha Venkatachalapathy, Sabina Sangaletti, Arianna Di Napoli, Davide Vacca, Silvia Lonardi, Luisa Lorenzi, Andrés J M Ferreri, Beatrice Belmonte, Gabriele Varano, Mario Paolo Colombo, Silvio Bicciato, Giorgio Inghirami, Leandro Cerchietti, Maurilio Ponzoni, Roberta Zappasodi, Fabio Facchetti, Marco Foiani, Stefano Casola, Anand D Jeyasekharan
The germinal center (GC) dark zone (DZ) and light zone (LZ) regions spatially separate expansion and diversification from selection of antigen-specific B-cells to ensure antibody affinity maturation and B cell memory. The DZ and LZ differ significantly in their immune composition despite the lack of a physical barrier, yet the determinants of this polarization are poorly understood. This study provides novel insights into signals controlling asymmetric T-cell distribution between DZ and LZ regions. We identify spatially-resolved DNA damage response and chromatin compaction molecular features that underlie DZ T-cell exclusion...
March 18, 2024: Research Square
https://read.qxmd.com/read/38562833/a-hiv-1-gp41-peptide-liposome-vaccine-elicits-neutralizing-epitope-targeted-antibody-responses-in-healthy-individuals
#40
Nathan B Erdmann, Wilton B Williams, Stephen R Walsh, Nicole Grunenberg, Paul T Edlefsen, Paul A Goepfert, Derek W Cain, Kristen W Cohen, Janine Maenza, Kenneth H Mayer, Hong Van Tieu, Magdalena E Sobieszczyk, Edith Swann, Huiyin Lu, Stephen C De Rosa, Zachary Sagawa, M Anthony Moody, Christopher B Fox, Guido Ferrari, R J Edwards, Priyamvada Acharya, S Munir Alam, Robert Parks, Margaret Barr, Georgia D Tomaras, David C Montefiori, Peter B Gilbert, M Juliana McElrath, Lawrence Corey, Barton F Haynes, Lindsey R Baden
BACKGROUND: HIV-1 vaccine development is a global health priority. Broadly neutralizing antibodies (bnAbs) which target the HIV-1 gp41 membrane-proximal external region (MPER) have some of the highest neutralization breadth. An MPER peptide-liposome vaccine has been found to expand bnAb precursors in monkeys. METHODS: The HVTN133 phase 1 clinical trial ( NCT03934541 ) studied the MPER-peptide liposome immunogen in 24 HIV-1 seronegative individuals. Participants were recruited between 15 July 2019 and 18 October 2019 and were randomized in a dose-escalation design to either 500 mcg or 2000 mcg of the MPER-peptide liposome or placebo...
March 18, 2024: medRxiv
keyword
keyword
16358
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.